PO attenuated HFD-induced colon inflammation in WT mice by attenuating the intestinal barrier protection, suppressing the NF-κB pathway, and decreasing the expression of pro-inflammatory genes, which might be attributed to the activation of GPR120. The gene discussed is FFAR4; the disease is colitis.